This HTML5 document contains 48 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n13http://linked.opendata.cz/ontology/domain/vavai/riv/typAkce/
dctermshttp://purl.org/dc/terms/
n14http://purl.org/net/nknouf/ns/bibtex#
n6http://localhost/temp/predkladatel/
n11http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n5http://linked.opendata.cz/ontology/domain/vavai/
n15http://linked.opendata.cz/resource/domain/vavai/zamer/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00216208%3A11160%2F01%3A00104586%21RIV%2F2002%2FMSM%2F111602%2FN/
n9http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n8http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n18http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n12http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n20http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n17http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n10http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00216208%3A11160%2F01%3A00104586%21RIV%2F2002%2FMSM%2F111602%2FN
rdf:type
n5:Vysledek skos:Concept
dcterms:description
Reduction of the Potential Anticancer drug Oracin Reduction of the Potential Anticancer drug Oracin
dcterms:title
Reduction of the Potential Anticancer drug Oracin in the Rat Gut Lumen and Wall Reduction of the Potential Anticancer drug Oracin in the Rat Gut Lumen and Wall
skos:prefLabel
Reduction of the Potential Anticancer drug Oracin in the Rat Gut Lumen and Wall Reduction of the Potential Anticancer drug Oracin in the Rat Gut Lumen and Wall
skos:notation
RIV/00216208:11160/01:00104586!RIV/2002/MSM/111602/N
n3:strany
12;12
n3:aktivita
n12:Z
n3:aktivity
Z(MSM 111600002)
n3:dodaniDat
n10:2002
n3:domaciTvurceVysledku
n11:6680895 n11:5711347 n11:2270455 n11:4698479 n11:2442256
n3:druhVysledku
n17:D
n3:duvernostUdaju
n8:S
n3:entitaPredkladatele
n7:predkladatel
n3:idSjednocenehoVysledku
694226
n3:idVysledku
RIV/00216208:11160/01:00104586
n3:jazykVysledku
n18:eng
n3:klicovaSlova
Anticancer drug; Oracin
n3:klicoveSlovo
n9:Oracin n9:Anticancer%20drug
n3:kontrolniKodProRIV
[D8AB6E3EDF7E]
n3:mistoKonaniAkce
DK
n3:mistoVydani
DK
n3:nazevZdroje
Benzon Symposium No.48, Drug Metabolism: Regulation and Importance; Copenhagen
n3:obor
n20:CE
n3:pocetDomacichTvurcuVysledku
5
n3:pocetTvurcuVysledku
5
n3:pocetUcastnikuAkce
0
n3:pocetZahranicnichUcastnikuAkce
0
n3:rokUplatneniVysledku
n10:2001
n3:tvurceVysledku
Buchta, Vladimír Szotáková, Barbora Skálová, Lenka Wsól, Vladimír Jílek, Petr
n3:typAkce
n13:WRD
n3:zahajeniAkce
2001-01-01+01:00
n3:zamer
n15:MSM%20111600002
s:numberOfPages
1
n14:hasPublisher
Neuveden
n6:organizacniJednotka
11160